Journal
VACCINE
Volume 40, Issue 11, Pages 1643-1654Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2021.04.013
Keywords
Influenza; Vaccine hesitancy; Vaccine coverage; Sex differences; Racial differences; Safety
Categories
Funding
- NIH/ORWH/NIA Specialized Center of Research Excellence in Sex Differences [U54AG062333]
Ask authors/readers for more resources
This review examined the impact of sociodemographic variables such as age, sex, race, and gender on influenza vaccine acceptance, coverage, and outcomes. The findings indicate that these factors significantly influence vaccine acceptance rates and outcomes to varying degrees.
Background: Influenza is a significant threat to public health worldwide. Despite the widespread availability of effective and generally safe vaccines, the acceptance and coverage of influenza vaccines are significantly lower than recommended. Sociodemographic variables are known to be potential predictors of differential influenza vaccine uptake and outcomes. Objectives: This review aims to (1) identify how sociodemographic characteristics such as age, sex, gender, and race may influence seasonal influenza vaccine acceptance and coverage; and (2) evaluate the role of these sociodemographic characteristics in differential adverse reactions among vaccinated individuals. Methods: PubMed was used as the database to search for published literature in three thematic areas related to the seasonal influenza vaccine -vaccine acceptance, adverse reactions, and vaccine coverage. Results: A total of 3249 articles published between 2010 and 2020 were screened and reviewed, of which 39 studies were included in this literature review. By the three thematic areas, 17 studies assessed vaccine acceptance, 8 studies focused on adverse reactions, and 14 examined coverage of the seasonal influenza vaccine. There were also two studies that focused on more than one of the areas of interest. Conclusion: Each of the four sociodemographic predictors - age, sex, race, and gender - were found to significantly influence vaccine acceptance, receipt and outcomes in this review. (c) 2021 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available